Differential natural killer cell–mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes

Partners AIDS Research Center and Infectious Disease Unit, Massachusetts General Hospital and Division of AIDS, Harvard Medical School, Boston, MA 02129, USA.
Journal of Experimental Medicine (Impact Factor: 13.91). 12/2007; 204(12):3027-36. DOI: 10.1084/jem.20070695
Source: PubMed

ABSTRACT Decline of peak viremia during acute HIV-1 infection occurs before the development of vigorous adaptive immunity, and the level of decline correlates inversely with the rate of AIDS progression, implicating a potential role for the innate immune response in determining disease outcome. The combined expression of an activating natural killer (NK) cell receptor, the killer immunoglobulin-like receptor (KIR) 3DS1, and its presumed ligand, human leukocyte antigen (HLA)-B Bw4-80I, has been associated in epidemiological studies with a slow progression to AIDS. We examined the functional ability of NK cells to differentially control HIV-1 replication in vitro based on their KIR and HLA types. NK cells expressing KIR3DS1 showed strong, significant dose- and cell contact-dependent inhibition of HIV-1 replication in target cells expressing HLA-B Bw4-80I compared with NK cells that did not express KIR3DS1. Furthermore, KIR3DS1+ NK cells and NKLs were preferentially activated, and lysed HIV-1 infected target cells in an HLA-B Bw4-80I-dependent manner. These data provide the first functional evidence that variation at the KIR locus influences the effectiveness of NK cell activity in the containment of viral replication.

Download full-text


Available from: Todd M Allen, Aug 20, 2015
  • Source
    • "NK cells sense this loss (loss of self) through KIR and respond vigorously by directly killing the infected or malignant target cells or by releasing cytokines which recruit other immune cells [12] [13]. Some KIR genes have been associated with increased susceptibility or resistance to infectious, autoimmune and metabolic diseases [14] [15] [16] [17] [18] [19]. NK cells were initially identified by their ability to spontaneously kill tumour cells without prior sensitisation [20] [21] [22]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: a b s t r a c t Killer-cell immunoglobulin-like receptors (KIR) are membrane proteins expressed by natural killer cells and CD8 lymphocytes. The KIR system consists of 17 genes and 614 alleles, some of which bind human leukocyte antigens (HLA). Both KIR and HLA modulate susceptibility to haematological malignancies, viral infections and autoimmune diseases. Molecular epidemiology studies employ traditional statistical methods to identify links between KIR genes and disease. Here we describe our results at applying artificial intelligence algorithms (support vector machines) to identify associations between KIR genes and disease. We demonstrate that these algorithms are capable of classifying samples into healthy and diseased groups based solely on KIR genotype with potential use in clinical decision support systems.
    Computers in Biology and Medicine 09/2013; 43(1):2053-2062. DOI:10.1016/j.compbiomed.2013.09.027 · 1.46 Impact Factor
  • Source
    • "Studies of virus specific T-and B-cell responses have been much at the center of these efforts, and have linked several key features of the adaptive immune response with relative viral control in vivo [67] [68] [69] [70] [71] [72] [73] [74] [75] [76]; Figure 3). More recent studies have also revealed potentially crucial factors of the innate immune system in this control, although in some cases, the mechanistic details remain to be defined and may involve virus capture and transfer as well as immune modulation by dendritic cells [77] [78] [79] [80] [81] [82]. Common to many of these correlative ex vivo studies or in vitro assays is that they often cannot discriminate between the cause and effects of controlled HIV infection, leaving the field still in the obscure what factors directly and actively mediate anti-viral effects. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Infections with HIV represent a great challenge for the development of strategies for an effective cure. The spectrum of diseases associated with HIV ranges from opportunistic infections and cancers to systemic physiological disorders like encephalopathy and neurocognitive impairment. A major progress in controlling HIV infection has been achieved by highly active antiretroviral therapy (HAART). However, HAART does neither eliminate the virus reservoirs in form of latently infected cells nor does it completely reconstitute immune reactivity and physiological status. Furthermore, the failure of the STEP vaccine trial and the only marginal efficacies of the RV144 trial together suggest that the causal relationships between the complex sets of viral and immunological processes that contribute to protection or disease pathogenesis are still poorly understood. Here, we provide an up-to-date overview of HIV-host interactions at the cellular, the immune system and the neuroendocrine systems level. Only by integrating this multi-level knowledge one will be able to handle the systems complexity and develop new methodologies of analysis and prediction for a functional restoration of the immune system and the health of the infected host.
    International Reviews Of Immunology 04/2013; 32(3). DOI:10.3109/08830185.2013.779375 · 5.28 Impact Factor
  • Source
    • "In contrast, the natural ligand of KIR3DS1 has yet to be identified . Recent genetic and functional studies have suggested that certain HLA-Bw4 molecules containing an isoleucine in position 80 (HLA-Bw4-I80) are a potential putative ligand for KIR3DS1 (Martin et al., 2002; Alter et al., 2007, 2009). However, despite several attempts by different groups, direct interactions between KIR3DS1 and HLA-Bw4 molecules have not yet been demonstrated (Carr et al., 2007; Gillespie et al., 2007; O'Connor et al., 2007), with the exception of one report by Li et al. (2010) suggesting interactions between KIR3DS1 and the HLA-Bw4-T80 allotype "
    [Show abstract] [Hide abstract]
    ABSTRACT: The function of natural killer (NK) cells is controlled by several activating and inhibitory receptors, including the family of killer-immunoglobulin-like receptors (KIRs). One distinctive feature of KIRs is the extensive number of various haplotypes generated by the gene content within the KIR gene locus as well as by highly polymorphic members of the KIR gene family, namely KIR3DL1/S1. Within the KIR3DL1/S1 gene locus, KIR3DS1 represents a conserved allelic variant and displays other unique features in comparison to the highly polymorphic KIR3DL1 allele. KIR3DS1 is present in all human populations and belongs to the KIR haplotype group B. KIR3DS1 encodes for an activating receptor featuring the characteristic short cytoplasmic tail and a positively charged residue within the transmembrane domain, which allows recruitment of the ITAM-bearing adaptor molecule DAP12. Although HLA class I molecules are thought to represent natural KIR ligands, and HLA-Bw4 molecules serve as ligands for KIR3DL1, the ligand for KIR3DS1 still needs to be identified. Despite the lack of formal evidence for an interaction of KIR3DS1 with HLA-Bw4-I80 or any other HLA class I subtype to date, a growing number of associations between the presence of KIR3DS1 and the outcome of viral infections have been described. Especially, the potential protective role of KIR3DS1 in combination with HLA-Bw4-I80 in the context of HIV-1 infection has been studied intensively. In addition, a number of recent studies have associated the presence or absence of KIR3DS1 with the occurrence and outcome of some malignancies, autoimmune diseases, and graft-versus-host disease (GVHD). In this review, we summarize the present knowledge regarding the characteristics of KIRD3S1 and discuss its role in various human diseases.
    Frontiers in Immunology 11/2012; 3:326. DOI:10.3389/fimmu.2012.00326
Show more